OHMR features A/Prof Paul Ekert and CRISPR
News Stories
The Office of Health and Medical Research (OHMR) has featured Associate Professor Paul Ekert‘s cutting-edge use of CRISPR technology in an article entitled ‘How ‘genetic scissors’ are helping researchers identify new drug targets for child cancers.’
Paul’s research is part of the Luminesce Alliance Translational Biology Project supported with funding assistance from OHMR. It uses a cutting-edge technology called CRISPR (which stands for ‘clustered regularly interspaced short palindromic repeats’) Cas13 system because it specifically cuts RNA and interrupts production of proteins.
“By targeting the production of proteins and not changing genes, we hope that the precision drugs we identify will cause fewer side effects” says Paul.